Pre-analytical Quality Indicators: Why Do They Matter?

Supported by SARSTEDT


Pre-analytical quality indicators such as rejected specimen rates, patient blood management, and total turnaround time for testing results are directly linked to patient care and outcomes as well as efficient patient discharge. Discover the hidden costs of poor quality in the pre-analytical phase of laboratory testing that affect not only the laboratory but the healthcare organization as a whole. The Lean Six Sigma approach to improving patient outcomes requires a collaborative approach, and understanding the pitfalls for a poor quality laboratory specimen is just the beginning. Healthcare providers are seeking to process improvements to reduce and eliminate pre-analytical laboratory errors; maybe it’s time to consider new methods and tools.


Cindy Brawley, MT(AMT), MHA
Diagnostic Product Manager